This research is the first to provide a comprehensive analysis of SF3B6 expression levels, clinical relevance, and potential roles across pan-cancer, further exploring its mechanisms in HCC through bioinformatics and in vitro experimental methods. This evidence concerns the gene SF3B6 and hepatocellular carcinoma.